| Demographic parameter |
Omalizumab powder for solution |
Omalizumab solution |
Total |
| No. of subjects, n |
81 |
74 |
155 |
Age (years), mean ± SD
(range) |
36.3 ± 12.9
(18–63) |
32.9 ± 11.4
(18–64) |
34.7 ± 12.4
(18–64) |
Weight (kg), mean ± SD
(range) |
70.8 ± 11.8
(47.4–90.0) |
70.5 ± 11.7
(47.3–90.0) |
70.6 ± 11.7
(47.3–90.0) |
| Gender, n (%) |
|
| Male |
31 (38.3) |
27 (36.5) |
58 (37.4) |
| Female |
50 (61.7) |
47 (63.5) |
97 (62.6) |
| Race, n (%) |
|
| Caucasians |
60 (74.1) |
55 (74.3) |
115 (74.2) |
| African–Americans |
9 (11.1) |
10 (13.5) |
19 (12.3) |
| Others |
12 (14.8) |
9 (12.2) |
21 (13.5) |
SD = standard deviation |
